Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer

BMC Cancer

Table 1 Expression of ZG16 in normal and diseased colorectal epithelium

Diagnosis	Immunohistochemistry (IHC)	Positive cells %	Number of cases
Normal Colon	strong (+++)	95	n = 30
Polyps-PJS	strong (+++)	95	n = 2
Polyps-JPS	Positive (++) to negative	50	n = 3
TA with LGD	Positive (++) to negative	15	n = 4
TVA with LGD	Positive (+) to negative	10	n = 6
Acute Colitis	Positive (+++)	95	n = 1
CUC without colon cancer	Positive (++) to negative	20	n = 4
CUC with colon cancer	Positive (+) to negative	10	n = 2
Colorectal adenocarcinoma	negative	0	n = 25
Colorectal mucinous adenocarcinoma	negative	0	n = 15

PJS: Peutz-Jeghers syndrome, JPS: juvenile polyposis syndrome, TA: tubulous adenoma, LGD: low grade dysplaxia, TVA: tubulovillous adenoma, CUC: chronic ulcerative colitis

ISSN: 1471-2407